Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Paramasivam Palaniyandi"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ahamed Fayaz, Shaik, Babu, Lakshmanan, Paridayal, Loganathan, Vasantha, Mahalingam, Paramasivam, Palaniyandi, Sundarakumar, Karuppasamy, Ponnuraja, Chinnaiyan
Publikováno v:
PLoS ONE; 10/16/2024, Vol. 19 Issue 10, p1-11, 11p
Autor:
Devarajulu Reddy Sirasanambati, Santhanakrishnan Ramesh Kumar, Gomathi Sivaramakrishnan, Geetha Ramachandran, Luke Elizabeth Hannah, Kandasamy Chandrasekaran, Ammayappan Radhakrishnan, Dina Nair, A. Mahilmaran, C Ponnuraja, Rathinam Sridhar, Mohan Natrajan, Perumal Venkatesan, Elangovan Thiruvalluvan, Pooranagangadevi Navaneethapandian, Gomathi Sekar, Kumaresan Soorappa Ponnusamy, M. S. Jawahar, Angamuthu Dhanalakshmi, Prabhakar Angamuthu, Soumya Swaminathan, Lavanya Jayabal, Dhanaraj Baskaran, Murugesan Raja Sakthivel, Kadayam Ranganathan Uma Devi, Banurekha Velayutham, Paramasivam Paul Kumaran, Prabhakaran Rathinam, Dharuman Kalaiselvi, Srikanth Tripathy, Mahalingam Vasantha, Paramasivam Palaniyandi, Marimuthu Makesh Kumar, Daniel Bella Devaleenal
Publikováno v:
Tropical Medicine & International Health. 25:483-495
Shortening tuberculosis (TB) treatment duration is a research priority. We tested the efficacy and safety of 3- and 4-month regimens containing moxifloxacin in a randomised clinical trial in pulmonary TB (PTB) patients in South India.New, sputum-posi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9719db1004c2ae67f5ec1a418891fda5
https://doi.org/10.1111/tmi.13371
https://doi.org/10.1111/tmi.13371